A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Veracyte, Inc. stock. As of the latest transaction made, Gotham Asset Management, LLC holds 15,060 shares of VCYT stock, worth $495,775. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,060
Previous 10,441 44.24%
Holding current value
$495,775
Previous $231,000 41.13%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$18.86 - $23.55 $87,114 - $108,777
4,619 Added 44.24%
15,060 $326,000
Q1 2024

May 15, 2024

SELL
$21.0 - $29.1 $22,701 - $31,457
-1,081 Reduced 9.38%
10,441 $231,000
Q4 2023

Feb 14, 2024

SELL
$19.72 - $28.68 $666,989 - $970,043
-33,823 Reduced 74.59%
11,522 $316,000
Q3 2023

Nov 14, 2023

BUY
$22.33 - $29.92 $467,389 - $626,255
20,931 Added 85.73%
45,345 $1.01 Million
Q2 2023

Aug 14, 2023

BUY
$20.96 - $26.99 $257,619 - $331,734
12,291 Added 101.39%
24,414 $621,000
Q1 2023

May 15, 2023

SELL
$20.58 - $27.89 $1.2 Million - $1.62 Million
-58,092 Reduced 82.73%
12,123 $270,000
Q4 2022

Feb 14, 2023

BUY
$15.31 - $29.94 $623,208 - $1.22 Million
40,706 Added 137.94%
70,215 $1.67 Million
Q3 2022

Nov 14, 2022

SELL
$16.58 - $27.9 $15,916 - $26,784
-960 Reduced 3.15%
29,509 $490,000
Q2 2022

Aug 15, 2022

BUY
$15.45 - $29.52 $470,746 - $899,444
30,469 New
30,469 $606,000
Q4 2021

Feb 14, 2022

SELL
$36.09 - $53.79 $1.09 Million - $1.63 Million
-30,299 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$35.62 - $52.97 $1.08 Million - $1.6 Million
30,299 New
30,299 $1.41 Million
Q1 2020

May 15, 2020

SELL
$16.13 - $30.17 $152,751 - $285,709
-9,470 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$20.78 - $29.99 $377,032 - $544,138
-18,144 Reduced 65.71%
9,470 $264,000
Q3 2019

Nov 14, 2019

SELL
$23.87 - $30.93 $86,361 - $111,904
-3,618 Reduced 11.58%
27,614 $663,000
Q2 2019

Aug 14, 2019

BUY
$22.1 - $28.56 $690,227 - $891,985
31,232 New
31,232 $890,000

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $2.36B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track Joel Greenblatt's Portfolio

Track Joel Greenblatt Portfolio

Follow Joel Greenblatt (Gotham Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.